Nearly 90% of ccRCC tumors have a loss of heterozygosity at chromosome 3p, with a resulting loss of function of the pVHL tumor suppression protein (von Hippel-Lindau), leading to the activation of the hypoxia inducible factor-2-alpha (HIF-2α) transcription factor. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.